Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs

NCT02449031 · clinicaltrials.gov ↗

COMPLETED

Status

409

Enrollment

INDUSTRY

Sponsor class

Conditions

Pseudomonas Aeruginosa in Cystic Fibrosis

Interventions

DRUG: TOBI® PODHALER®
DRUG: TOBI®
DRUG: Bethkis®
DRUG: Cayston®

Sponsor

Mylan Inc.

Collaborators

[object Object]